AI chatbot could help patients with early Heart-Kidney-Metabolic syndrome feel better and stay out of hospital
NCT ID NCT07577284
First seen May 14, 2026 · Last updated May 16, 2026 · Updated 1 time
Summary
This study tests whether an AI chatbot, combined with nurse support, can help adults with early-stage cardiovascular-kidney-metabolic (CKM) syndrome better manage their symptoms. About 72 participants will either use the chatbot with nurse feedback or just report symptoms without feedback. The goal is to see if the chatbot reduces symptom burden and lowers emergency visits and hospital stays.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR KIDNEY METABOLIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Taipei Medical University
Taipei, No. 250號, Wuxing St, Xinyi District, Taipei City, 110, Taiwan
Conditions
Explore the condition pages connected to this study.